S G Shchur Selected Research

Interferon beta-1b (Betaseron)

1/2006

[The results of longitudinal use of copaxone and betaferon in Moscow Multiple Sclerosis Center: issues of efficacy and adherence to therapy].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

S G Shchur Research Topics

Disease

9	Multiple Sclerosis 01/2019 - 01/2006
2	Relapsing-Remitting Multiple Sclerosis 01/2022 - 01/2013
1	Chronic Progressive Multiple Sclerosis 01/2013
1	Disease Progression 01/2012

Drug/Important Bio-Agent (IBA)

4	Interferon beta-1a FDA Link 01/2022 - 01/2011
3	Pharmaceutical PreparationsIBA 01/2022 - 01/2012
3	Glatiramer Acetate (Copaxone)FDA Link 01/2012 - 01/2006
2	InterferonsIBA 01/2022 - 01/2015
2	Biosimilar PharmaceuticalsIBA 01/2013 - 01/2012
1	AntigensIBA 01/2019
1	antineoplaston A10 (A 10)IBA 01/2012
1	Acetates (Acetic Acid Esters)FDA Link 01/2012
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2011
1	CTLA-4 AntigenIBA 11/2011
1	CCR5 Receptors (CCR5 Receptor)IBA 11/2011
1	Histocompatibility Antigens Class IIIBA 11/2011
1	Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA 11/2011
1	Interleukin-7 Receptor alpha SubunitIBA 11/2011
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 11/2011
1	Interferon-betaIBA 01/2011
1	Interferon beta-1b (Betaseron)FDA Link 01/2006

Therapy/Procedure

2	Therapeutics 01/2022 - 01/2006
1	Intramuscular Injections 01/2022
1	Subcutaneous Injections 01/2015
1	Immunotherapy 11/2011